TNBC study on Triple Negative Breast Cancer originating in Stem Cells vs specialized cells and how inhibitor of differentiation 4 (ID4) gene plays a role in cells dividing in stem cells.
Click link to full story:
* I was quoted at the end of this article:
Five-year TNBC survivor Melissa Paskvan of Toledo, Ohio says the study gives her hope for those who will be diagnosed in the future. “TNBC survivors have been longing for a targeted therapy for some time now. This could be a game-changing discovery in how we treat TNBC in improving survival outcome in patients.”